Hirotsugu Kenmotsu. "Combination of Osimertinib and Vascular Endothelial Growth Factor Receptor Inhibitors for
            <i>EGFR</i>
            -Mutated Non–Small Cell Lung Cancer: Old or New Regimen?." Journal of Clinical Oncology, 2025. doi:10.1200/jco-24-01921